Annelize Koch
Merthyr Tydfil, WLS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants.
Journal: Advances in therapy
Published: July 22, 2024
A Phase 1 randomized study on the safety and pharmacokinetics of OCS-05, a neuroprotective disease modifying treatment for Acute Optic Neuritis and Multiple Sclerosis.
Journal: Scientific reports
Published: December 30, 2022
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria.
Journal: Kidney international
Published: May 13, 2021
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges.
Journal: Frontiers in pharmacology
Published: July 06, 2020
Impact of the Selective Orexin-1 Receptor Antagonist ACT-539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male Subjects.
Journal: Journal of clinical pharmacology
Published: December 19, 2019
Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti-CD38 cytolytic antibody TAK-079 in healthy subjects.
Journal: British journal of clinical pharmacology
Published: December 20, 2018
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development.
Journal: Frontiers in pharmacology
Published: September 11, 2018
Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting.
Journal: Regulatory toxicology and pharmacology : RTP
Published: September 18, 2017
First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases.
Journal: European journal of clinical pharmacology
Published: October 13, 2016
GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes.
Journal: British journal of clinical pharmacology
Published: July 29, 2016
Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and alprazolam following insulin-induced hypoglycemia in humans.
Journal: Psychopharmacology
Published: October 08, 2013
Effect of dopamine D₃ receptor antagonism on approach responses to food cues in overweight and obese individuals.
Journal: Behavioural pharmacology
Published: July 10, 2012
Last Updated: 09/26/2026